These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

889 related articles for article (PubMed ID: 28279820)

  • 21. Impact of lymphoma-linked Asn11Tyr point mutation on the interaction between Bcl-2 and a BH3 mimetic: Insights from molecular dynamics simulation.
    Singh K; Briggs JM
    Chem Biol Drug Des; 2020 Apr; 95(4):435-450. PubMed ID: 32030875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands.
    Day CL; Chen L; Richardson SJ; Harrison PJ; Huang DC; Hinds MG
    J Biol Chem; 2005 Feb; 280(6):4738-44. PubMed ID: 15550399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugs.
    Diepstraten ST; Young S; La Marca JE; Wang Z; Kluck RM; Strasser A; Kelly GL
    Cell Death Differ; 2023 Apr; 30(4):1005-1017. PubMed ID: 36755070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theoretical study on the selective binding of BH3-only protein BAD to anti-apoptotic protein BCL-
    Wang P; Cui J; Cheng G; Zhang D
    Phys Chem Chem Phys; 2024 Oct; 26(39):25480-25487. PubMed ID: 39324232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL.
    Dutta S; Gullá S; Chen TS; Fire E; Grant RA; Keating AE
    J Mol Biol; 2010 May; 398(5):747-62. PubMed ID: 20363230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak.
    Cao X; Yap JL; Newell-Rogers MK; Peddaboina C; Jiang W; Papaconstantinou HT; Jupitor D; Rai A; Jung KY; Tubin RP; Yu W; Vanommeslaeghe K; Wilder PT; MacKerell AD; Fletcher S; Smythe RW
    Mol Cancer; 2013 May; 12(1):42. PubMed ID: 23680104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residue-Based Preorganization of BH3-Derived α/β-Peptides: Modulating Affinity, Selectivity and Proteolytic Susceptibility in α-Helix Mimics.
    Peterson-Kaufman KJ; Haase HS; Boersma MD; Lee EF; Fairlie WD; Gellman SH
    ACS Chem Biol; 2015 Jul; 10(7):1667-75. PubMed ID: 25946900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
    Zhang S; Long A; Link AJ
    ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions.
    Moroy G; Martin E; Dejaegere A; Stote RH
    J Biol Chem; 2009 Jun; 284(26):17499-511. PubMed ID: 19293158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain.
    Boersma MD; Haase HS; Peterson-Kaufman KJ; Lee EF; Clarke OB; Colman PM; Smith BJ; Horne WS; Fairlie WD; Gellman SH
    J Am Chem Soc; 2012 Jan; 134(1):315-23. PubMed ID: 22040025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side-by-side comparison of BH3-mimetics identifies MCL-1 as a key therapeutic target in AML.
    Ewald L; Dittmann J; Vogler M; Fulda S
    Cell Death Dis; 2019 Dec; 10(12):917. PubMed ID: 31801941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells.
    Foight GW; Ryan JA; Gullá SV; Letai A; Keating AE
    ACS Chem Biol; 2014 Sep; 9(9):1962-8. PubMed ID: 25052212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
    Santiveri CM; Sborgi L; de Alba E
    J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes.
    Fire E; Gullá SV; Grant RA; Keating AE
    Protein Sci; 2010 Mar; 19(3):507-19. PubMed ID: 20066663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural biology of the Bcl-2 family of proteins.
    Petros AM; Olejniczak ET; Fesik SW
    Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural transitions in TCTP tumor protein upon binding to the anti-apoptotic protein family member Mcl-1.
    Malard F; Sizun C; Thureau A; Carlier L; Lescop E
    J Biol Chem; 2023 Jul; 299(7):104830. PubMed ID: 37201583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico and in vitro elucidation of BH3 binding specificity toward Bcl-2.
    London N; Gullá S; Keating AE; Schueler-Furman O
    Biochemistry; 2012 Jul; 51(29):5841-50. PubMed ID: 22702834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of synergy of BH3 mimetics and paclitaxel in chronic myeloid leukemia cells: Mcl-1 inhibition.
    Song T; Chai G; Liu Y; Xie M; Chen Q; Yu X; Sheng H; Zhang Z
    Eur J Pharm Sci; 2015 Apr; 70():64-71. PubMed ID: 25596561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting effective pro-apoptotic anti-leukaemic drug combinations using co-operative dynamic BH3 profiling.
    Grundy M; Seedhouse C; Jones T; Elmi L; Hall M; Graham A; Russell N; Pallis M
    PLoS One; 2018; 13(1):e0190682. PubMed ID: 29298347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode.
    Hedir S; De Giorgi M; Fogha J; De Pascale M; Weiswald LB; Brotin E; Marekha B; Denoyelle C; Denis C; Suzanne P; Gautier F; Juin P; Ligat L; Lopez F; Carlier L; Legay R; Bureau R; Rault S; Poulain L; Oliveira Santos JS; Voisin-Chiret AS
    Eur J Med Chem; 2018 Nov; 159():357-380. PubMed ID: 30308410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.